Literature DB >> 2691346

Lipid related consequences of intestinal malabsorption.

G R Thompson1.   

Abstract

The small intestine plays a key role in lipid metabolism by absorbing fat and synthesising apoproteins. Fat malabsorption secondary to intestinal disease results in abnormalities of lipoprotein concentration and composition and can lead to deficiency of essential fatty acids and fat-soluble vitamins. Malabsorption of fat can be induced by administration of neomycin and malabsorption of bile acids by administration of anion-exchange resins or by creating a partial ileal bypass. These induced forms of malabsorption are useful in the treatment of hyperlipidaemic patients liable to atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2691346      PMCID: PMC1440688          DOI: 10.1136/gut.30.spec_no.29

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  20 in total

1.  Electron microscopic studies of the assembly, intracellular transport, and secretion of chylomicrons by rat intestine.

Authors:  S M Sabesin; S Frase
Journal:  J Lipid Res       Date:  1977-07       Impact factor: 5.922

2.  Relative contributions by liver and intestine to individual plasma apolipoproteins in the rat.

Authors:  A L Wu; H G Windmueller
Journal:  J Biol Chem       Date:  1979-08-10       Impact factor: 5.157

3.  Plasma post-heparin lipolytic activity in patients with malabsorption: effect of intravenous fat administration.

Authors:  M Press; G R Thompson
Journal:  Clin Sci Mol Med       Date:  1974-06

4.  Effect of neomycin on cholesterol metabolism in the germ-free pig.

Authors:  G R Thompson; K Henry; N Edington; P C Trexler
Journal:  Eur J Clin Invest       Date:  1972-08       Impact factor: 4.686

5.  Lymphatic and portal venous transport of alpha-tocopherol and cholesterol.

Authors:  M T MacMahon; G Neale; G R Thompson
Journal:  Eur J Clin Invest       Date:  1971-01       Impact factor: 4.686

6.  Superiority of partial ileal bypass over cholestyramine reducing cholesterol in familial hypercholesterolaemia.

Authors:  F A Spengel; A Jadhav; R G Duffield; C B Wood; G R Thompson
Journal:  Lancet       Date:  1981-10-10       Impact factor: 79.321

Review 7.  Intestinal lipoprotein metabolism.

Authors:  P H Green; R M Glickman
Journal:  J Lipid Res       Date:  1981-11       Impact factor: 5.922

8.  Difference in saturable binding of low density lipoprotein to liver membranes from normocholesterolemic subjects and patients with heterozygous familial hypercholesterolemia.

Authors:  K Harders-Spengel; C B Wood; G R Thompson; N B Myant; A K Soutar
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

9.  Fatty acid composition of plasma lipoproteins in control subjects and in patients with malabsorption.

Authors:  T Shimoyama; H Kikuchi; M Press; G R Thompson
Journal:  Gut       Date:  1973-09       Impact factor: 23.059

10.  Efficacy of mevinolin as adjuvant therapy for refractory familial hypercholesterolaemia.

Authors:  G R Thompson; J Ford; M Jenkinson; I Trayner
Journal:  Q J Med       Date:  1986-08
View more
  5 in total

1.  The potential role of vitamin D supplementation as a gut microbiota modifier in healthy individuals.

Authors:  Parul Singh; Arun Rawat; Mariam Alwakeel; Elham Sharif; Souhaila Al Khodor
Journal:  Sci Rep       Date:  2020-12-10       Impact factor: 4.379

2.  Spinal epidural and synovial lipomatosis in a 3-year-old Eurasian dog receiving sustained steroid therapy.

Authors:  Marion Signoret; Lucile Gros; Renaud Dumont; Claire Dally; Kevin Le Boedec; Laurent Cauzinille
Journal:  Vet Med Sci       Date:  2022-06-22

3.  The effect of the gastrointestinal lipase inhibitor, orlistat, on serum lipids and lipoproteins in patients with primary hyperlipidaemia.

Authors:  S Tonstad; D Pometta; D W Erkelens; L Ose; T Moccetti; J A Schouten; A Golay; J Reitsma; A Del Bufalo; E Pasotti
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

4.  LPS Inhibits Fatty Acid Absorption in Enterocytes through TNF-α Secreted by Macrophages.

Authors:  Heyuan Liu; Lixia Kai; Huahua Du; Xinxia Wang; Yizhen Wang
Journal:  Cells       Date:  2019-12-12       Impact factor: 6.600

5.  Comparison of clinical, clinicopathologic, and histologic variables in dogs with chronic inflammatory enteropathy and low or normal serum 25-hydroxycholecalciferol concentrations.

Authors:  Sara A Wennogle; Simon L Priestnall; Alejandro Suárez-Bonnet; Craig B Webb
Journal:  J Vet Intern Med       Date:  2019-09-09       Impact factor: 3.175

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.